Pathological roles of mitochondrial dysfunction in endothelial cells during the cerebral no-reflow phenomenon: A review

Medicine (Baltimore). 2024 Dec 20;103(51):e40951. doi: 10.1097/MD.0000000000040951.

Abstract

Emergency intravascular interventional therapy is the most effective approach to rapidly restore blood flow and manage occlusion of major blood vessels during the initial phase of acute ischemic stroke. Nevertheless, several patients continue to experience ineffective reperfusion or cerebral no-reflow phenomenon, that is, hypoperfusion of cerebral blood supply after treatment. This is primarily attributed to downstream microcirculation disturbance. As integral components of the cerebral microvascular structure, endothelial cells (ECs) attach importance to regulating microcirculatory blood flow. Unlike neurons and microglia, ECs harbor a relatively low abundance of mitochondria, acting as key sensors of environmental and cellular stress in regulating the viability, structural integrity, and function of ECs rather than generating energy. Mitochondria dysfunction including increased mitochondrial reactive oxygen species levels and disturbed mitochondrial dynamics causes endothelial injury, further causing microcirculation disturbance involved in the cerebral no-reflow phenomenon. Therefore, this review aims to discuss the role of mitochondrial changes in regulating the role of ECs and cerebral microcirculation blood flow during I/R injury. The outcomes of the review will provide promising potential therapeutic targets for future prevention and effective improvement of the cerebral no-reflow phenomenon.

Publication types

  • Review

MeSH terms

  • Cerebrovascular Circulation / physiology
  • Endothelial Cells* / metabolism
  • Endothelial Cells* / physiology
  • Humans
  • Microcirculation / physiology
  • Mitochondria* / metabolism
  • Mitochondria* / physiology
  • No-Reflow Phenomenon* / physiopathology
  • Reactive Oxygen Species / metabolism

Substances

  • Reactive Oxygen Species